Möchten Sie immer auf dem neuesten Stand bleiben?

New York, United States , Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Global Genetic Engineering Market Size is to Grow from USD 1.35 Billion in 2023 to USD 8.95 Billion by 2033, at a Compound Annual...

September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Treat Advanced Ovarian Cancer and Clinical Development Timeline ...

Burlingame, Sept. 09, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, RNA Therapeutics Market is estimated to value at US$ 2.5 Million in the year 2024 and is anticipated to reach...

DUBAI, United Arab Emirates, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is set to ignite at Token 2049 Singapore, one of the...

  NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation and pioneer in medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ:...

9 SEPTEMBER 2024 NORTHERN 2 VCT PLC THE NORTHERN VCTS EXIT GENTRONIX Northern 2 VCT PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1999 and managed by Mercia Fund Management...

9 SEPTEMBER 2024 NORTHERN VENTURE TRUST PLC THE NORTHERN VCTS EXIT GENTRONIX Northern Venture Trust PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1995 and advised by Mercia...

9 SEPTEMBER 2024 NORTHERN 3 VCT PLC THE NORTHERN VCTS EXIT GENTRONIX Northern 3 VCT PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 2001 and managed by Mercia Fund Management...

SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Creyon Bio, Inc. ("Creyon"), a clinical-stage leader in AI/machine learning-enabled engineering of...

SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious...